-
Sep 19, 2014
-
Pharma majors to be hit as drug regulator caps prices
In a move that might impact major drug makers such as Ranbaxy, Cipla, Cadila Health, and Lupin, the National Pharmaceutical Pricing Authority (NPPA) has capped the prices of 19 medicines and their 43 different drug packs, including anti-infectives, gastro-intestinal drugs and vaccines.Among multinational companies, Pfizer, Sanofi and Reckitt Benckiser are likely to take a hit.NPPA has notified the ceiling price of these products under the Drugs Price Control Order, 2013.
Source -
http://www.business-standard.com
|